GT Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.About GTBP
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on its proprietary TriKE and Dual Targeting TriKE platforms. Its product candidates include GTB-3650, a CD33-targeted therapy for relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome, and GTB-5550, a B7-H3-targeted therapy for solid tumors.
GTBP Key Statistics
Stock Snapshot
As of today, GT Biopharma(GTBP) shares are valued at $3.95. The company's market cap stands at 8.12M, with a P/E ratio of -0.04.
On 2026-11-11, GT Biopharma(GTBP) stock moved within a range of $3.86 to $4.03. With shares now at $3.95, the stock is trading +2.4% above its intraday low and -2.0% below the session's peak.
Trading volume for GT Biopharma(GTBP) stock has reached 28.39K, versus its average volume of 64.54K.
The stock's 52-week range extends from a low of $3.86 to a high of $28.75.
The stock's 52-week range extends from a low of $3.86 to a high of $28.75.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.